These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7506731)
1. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1. Nickells MW; Alvarez JI; Lublin DM; Atkinson JP J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731 [TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. Spicer AP; Seldin MF; Gendler SJ J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711 [TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55). Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551 [TBL] [Abstract][Full Text] [Related]
4. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654 [TBL] [Abstract][Full Text] [Related]
5. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. Nonaka M; Miwa T; Okada N; Nonaka M; Okada H J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710 [TBL] [Abstract][Full Text] [Related]
6. Characterization of CR1- and membrane cofactor protein-like proteins of two primates. Nickells MW; Atkinson JP J Immunol; 1990 Jun; 144(11):4262-8. PubMed ID: 2140391 [TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor. Okada N; Tanaka H; Takizawa H; Okada H J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542 [TBL] [Abstract][Full Text] [Related]
8. Additional forms of human decay-accelerating factor (DAF). Seya T; Farries T; Nickells M; Atkinson JP J Immunol; 1987 Aug; 139(4):1260-7. PubMed ID: 2440950 [TBL] [Abstract][Full Text] [Related]
9. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332 [TBL] [Abstract][Full Text] [Related]
10. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. Iwata K; Seya T; Ariga H; Nagasawa S J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647 [TBL] [Abstract][Full Text] [Related]
11. Identification of 5'-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. Thomas DJ; Lublin DM J Immunol; 1993 Jan; 150(1):151-60. PubMed ID: 7678027 [TBL] [Abstract][Full Text] [Related]
12. Decay-accelerating factor (DAF) shares a common carbohydrate determinant with the variant surface glycoprotein (VSG) of the African Trypanosoma brucei. Davitz MA; Gurnett AM; Low MG; Turner MJ; Nussenzweig V J Immunol; 1987 Jan; 138(2):520-3. PubMed ID: 2432127 [TBL] [Abstract][Full Text] [Related]
14. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Caras IW; Davitz MA; Rhee L; Weddell G; Martin DW; Nussenzweig V Nature; 1987 Feb 5-11; 325(6104):545-9. PubMed ID: 2433596 [TBL] [Abstract][Full Text] [Related]
15. Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface. Tsuji S; Kaji K; Nagasawa S J Immunol; 1994 Feb; 152(3):1404-10. PubMed ID: 7507966 [TBL] [Abstract][Full Text] [Related]
16. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577 [TBL] [Abstract][Full Text] [Related]
17. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603 [TBL] [Abstract][Full Text] [Related]
18. Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor. Kawada M; Mizuno M; Nasu J; Uesu T; Okazaki H; Okada H; Shimomura H; Yamamoto K; Tsuji T; Fujita T; Shiratori Y J Lab Clin Med; 2003 Nov; 142(5):306-12. PubMed ID: 14647034 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. Walter EI; Roberts WL; Rosenberry TL; Ratnoff WD; Medof ME J Immunol; 1990 Feb; 144(3):1030-6. PubMed ID: 1688588 [TBL] [Abstract][Full Text] [Related]
20. Decay-accelerating factor functions as a signal transducing molecule for human T cells. Davis LS; Patel SS; Atkinson JP; Lipsky PE J Immunol; 1988 Oct; 141(7):2246-52. PubMed ID: 2459203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]